Company: Pfizer Inc

TheStreet.com details the 10 most popular high-yielding dividend stocks among Morningstar's Ultimate Stock-Pickers funds, listed in inverse order of highest yield.   Read More

With $3.5 trillion under management, BlackRock president Rob Kapito is always watching for opportunities. Here's what he's spotted.   Read More

Apple’s share price has rocketed in recent months, crossing both the $500 and $600 level within the space of mere weeks. So as analysts continually hike their price targets for the stock, is the only way really up?   Read More

When Mylan Inc. held its analyst day a few weeks ago, it offered an earnings per share forecast for (wait for it!) 2018.   Read More

The Dow is up. Unemployment is down. Car sales are booming, consumer spending has risen, and even home values have started to stabilize. However, the recession isn’t quite over yet.  Here is a tally of “the worst” so far in 2012.   Read More

The S&P Tech sector is showing another shade of its glory days. For the first time since the tech bubble popped back in 2000, technology companies have reclaimed a hefty 20 percent weighting in the S&P 500 index.   Read More

While this week’s rise toward 13,000 may be reminiscent of April 2007, today’s Dow Jones Industrial Average is quite different in composition than the average that hit that level nearly five years ago.   Read More

If you are one of those people who dismiss all the hype around Super Bowl advertising, I have one word for you: “Whassup?” Super Bowl ads aren't just noise between the action in the game, they are an important part of American culture, and Wordnik.com's Erin McKean has proof.    Read More

Cramer thinks big pharma stocks could soon pop, so here's his preferred plays.   Read More

The Fed’s decision to hold rates steady through 2014 puts a slew of stocks in play. How should you trade it?   Read More